NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Cera Sanitaryware Maintains Growth Momentum, Upgrades Earnings Estimates

Cera Sanitaryware (CRS) has reported a strong Q4FY26 performance, with revenue growth reaching double digits. The company's research report by Prabhudas Lilladher highlights that CRS expects similar growth in the coming quarters. In Q4FY26, the EBITDA margin contracted due to higher trade discounts and rising brass costs. However, with price hikes implemented in the sanitaryware and faucetware segments, the company expects the margin to remain stable at 14-15% in FY27.

The company has taken price hikes of approximately 12% in the sanitaryware segment and 16% in the faucetware segment in Q4FY26. CRS has guided for FY27 revenue growth of 18-20%, driven primarily by 18% growth in faucetware, 12% growth in sanitaryware, and a meaningful contribution from the Senator and Polypluz brands.

Upgraded Earnings Estimates

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In response to the company's performance, Prabhudas Lilladher has upgraded its earnings estimates by 5.5% for FY27 and 6.8% for FY28. The research firm estimates a revenue compound annual growth rate (CAGR) of 16.3%, EBITDA CAGR of 20.9%, and PAT CAGR of 24.1% over FY26-28E.

Maintained 'BUY' Rating and Target Price

Based on the analysis, Prabhudas Lilladher maintains its 'BUY' rating for CRS with a target price of INR 7,429, based on 30x Mar'28 earnings.

Investor Takeaway

Investors should consider buying Cera Sanitaryware with a target price of Rs 7429.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.